CN105878665A - 一种用于治疗痤疮的中药复配物及其制备方法 - Google Patents
一种用于治疗痤疮的中药复配物及其制备方法 Download PDFInfo
- Publication number
- CN105878665A CN105878665A CN201610188990.5A CN201610188990A CN105878665A CN 105878665 A CN105878665 A CN 105878665A CN 201610188990 A CN201610188990 A CN 201610188990A CN 105878665 A CN105878665 A CN 105878665A
- Authority
- CN
- China
- Prior art keywords
- folium
- traditional chinese
- radix
- acne
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 43
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 39
- 150000001875 compounds Chemical class 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 63
- 239000003814 drug Substances 0.000 claims abstract description 57
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims abstract description 34
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 32
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 32
- 239000011593 sulfur Substances 0.000 claims abstract description 32
- 229960005091 chloramphenicol Drugs 0.000 claims abstract description 25
- 238000002347 injection Methods 0.000 claims abstract description 25
- 239000007924 injection Substances 0.000 claims abstract description 25
- 239000000706 filtrate Substances 0.000 claims abstract description 24
- 241000628997 Flos Species 0.000 claims abstract description 23
- 238000010438 heat treatment Methods 0.000 claims abstract description 23
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 22
- 239000008589 Cortex Fraxini Substances 0.000 claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000001914 filtration Methods 0.000 claims abstract description 15
- 238000002791 soaking Methods 0.000 claims abstract description 9
- 238000000605 extraction Methods 0.000 claims abstract description 8
- 238000010992 reflux Methods 0.000 claims abstract description 8
- 239000000243 solution Substances 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims description 23
- 239000009286 sanguis draxonis Substances 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 15
- 230000006837 decompression Effects 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 7
- 235000011837 pasties Nutrition 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 10
- 230000028327 secretion Effects 0.000 abstract description 7
- 210000002374 sebum Anatomy 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 244000168525 Croton tiglium Species 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 244000280244 Luffa acutangula Species 0.000 abstract 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 abstract 1
- 244000018633 Prunus armeniaca Species 0.000 abstract 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 1
- 244000173853 Sanguisorba officinalis Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 19
- 230000000844 anti-bacterial effect Effects 0.000 description 15
- 229940097572 chloromycetin Drugs 0.000 description 9
- 229920000742 Cotton Polymers 0.000 description 6
- 241000186427 Cutibacterium acnes Species 0.000 description 6
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229940055019 propionibacterium acne Drugs 0.000 description 6
- 230000001629 suppression Effects 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000035784 germination Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000186429 Propionibacterium Species 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 229960003276 erythromycin Drugs 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 2
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 2
- 230000000895 acaricidal effect Effects 0.000 description 2
- 239000000642 acaricide Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 229960002227 clindamycin Drugs 0.000 description 2
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000035617 depilation Effects 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 229960003722 doxycycline Drugs 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 229960004023 minocycline Drugs 0.000 description 2
- JEIULZGUODBGJK-UHFFFAOYSA-N pentathionic acid Chemical compound OS(=O)(=O)SSSS(O)(=O)=O JEIULZGUODBGJK-UHFFFAOYSA-N 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 206010000501 Acne conglobata Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000489492 Arisaema Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
- -1 a-bisabolol Chemical compound 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229960000565 tazarotene Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了用于治疗痤疮的中药复配物,其中,将生杏仁、秦皮、苦楝皮,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英,甘草;混合一起后加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,经三次加热得三份滤液;将三次滤液合在一起,制得中药粉;将中药粉,硫磺,2ml∶0.25g的氯霉素注射液,倒入体积分数75%的酒精中浸泡48小时后,加热回流提取3次,每次2小时,将3次提取液合并,减压回收乙醇,并浓缩至药液浓度为0.5g生药/ml,即得。本发明配比简单,使用方便,杀菌效果好,抑制皮脂分泌,治疗痤疮快速见效且不易反复复发。
Description
技术领域
本发明涉及中药技术领域,特别涉及一种用于治疗粉刺的中药复配物及其制备方法。
背景技术
痤疮是常见的皮肤病,特征是皮肤区域具有皮脂溢:如鳞状红皮肤,粉刺:如黑头和白头,丘疹,脓疱,结节,瘢痕等。痤疮成因是多因素的,如毛囊被异常粘附的脱落细胞堵塞,细菌(疮疱丙酸杆菌)增殖和定殖导致局部炎症,以及毛囊角质化和皮脂生成异常。西药治疗法:抗生素,如红霉素、克林霉素和四环素已通过局部或口服给药来治疗痤疮。再如市面通用的化学杀菌剂、激素、收敛剂、抗炎剂等,如,局部外用药物-维A酸类(维A酸乳膏、阿达帕林凝胶、他扎罗汀凝胶)、过氧化苯甲酰、抗生素类(克林霉素、红霉素、氯霉素等)、壬二酸、硫磺洗剂等。口服抗生素-首选四环素类(米诺环素、多西环素等),其次为大环内酯类(红霉素),避免选择常用于治疗系统感染的抗生素如左氧氟沙星等。抗生素疗程通常6~12周。口服糖皮质激素-主要用于暴发性或聚合性痤疮。但是,上述治疗方法虽然能够在短时间内消除炎症,但是,由于没有能够从根本上解决痤疮的致病因素,不能够抑制皮脂腺的分泌,毛囊阻塞的根本原因没有解除,治标不治本,痤疮常常会很快就复发,出现此起彼伏的现象。此外,病菌对于化学性的杀菌剂容易产生耐药性,复发后的粉刺就更加难以治疗,形成顽固性痤疮,并且会并发疤痕和色素沉着,对皮肤产生灾难性的后果。
中药护肤品不但可以改善肤质,而且能够消炎,增加皮肤通透性。因此,市面上出现了多种针对痤疮的中药制品,例如:中国专利申请2014103993887公开了一种用于治疗痤疮的中药组合物包括按照重量单位配置的如下成分:黄芪15-25g,白术15-25g,熟地15-25g,紫苏梗15-20g,郁金15-20g,枇杷叶15-20g,茵陈15-20g,白僵蚕15-20g,生姜15-20g,桃仁10-15g,胆南星10-15g,皂角刺10-15g,五味子15-20g,杏仁10-15g,昆布10-15g,川芎10-15g,甘草8-12g。再如:中国专利申请2014100851210公开了一种去粉刺凝胶,由以下组分组成:虎杖提取物、小麦胚芽提取物、紫草提取物、向日葵提取物、玻尿酸提取物、青黛提取物、金银花提取物、竹盐、纳米珍珠粉、透明质酸钠、凝胶剂、多元醇、甘草酸二钾、吐温20、β-葡聚糖、a-红没药醇、尿囊素、乙醇、碱液、防腐抗菌剂和去离子水。本发明旨在现有技术的基础上,提供一种配比简单,使用方便,杀菌效果好,抑制皮脂分泌,治疗痤疮快速见效且不易反复复发的一种用于治疗痤疮的中药复配物及其制备方法。
发明内容:
本发明的目的在于提供一种配比简单,使用方便,杀菌效果好,抑制皮脂分泌,治疗痤疮快速见效且不易反复复发的一种用于治疗痤疮的中药复配物及其制备方法。
为了实现上述目的,本发明提供了一种用于治疗痤疮的中药复配物,其中,包括按照重量单位配置的如下成分:
生杏仁、秦皮、苦楝皮各60-80g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各40-60g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各20-40g,甘草10-20g;硫磺10-30g,2ml:0.25g的氯霉素注射液5-15支,体积分数75%的酒精2000-3000g。
或者,包括按照重量单位配置的如下成分:
生杏仁、秦皮、苦楝皮各60-70g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各40-50g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各20-30g,甘草10-15g;硫磺10-20g,2ml:0.25g的氯霉素注射液5-10支,体积分数75%的酒精2000-2500g。
或者,包括按照重量单位配置的如下成分:
生杏仁、秦皮、苦楝皮各70-80g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各50-60g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各30-40g,甘草15-20g;硫磺20-30g,2ml:0.25g的氯霉素注射液10-15支,体积分数75%的酒精2500-3000g。
或者,包括按照重量单位配置的如下成分:
生杏仁、秦皮、苦楝皮各65-75g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各45-55g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各25-35g,甘草12-18g;硫磺12-22g,2ml:0.25g的氯霉素注射液8-12支,体积分数75%的酒精2200-2600g。
为更好的实现本发明目的,本发明又公开了一种用于治疗痤疮的中药复配物的制备方法,其中,
将生杏仁、秦皮、苦楝皮,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英,甘草;
混合一起后加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在80℃,烘干后冷却,得中药粉;
将中药粉,硫磺,2ml:0.25g的氯霉素注射液,倒入体积分数75%的酒精中浸泡48小时后,加热回流提取3次,每次2小时,将3次提取液合并,减压回收乙醇,并浓缩至药液浓度为0.5g生药/ml,即得。
本发明使用时,用棉签或棉棒蘸上述所得药液,涂抹痤疮处,每日三次。
本发明配比简单,使用方便,杀菌效果好,抑制皮脂分泌,治疗痤疮快速见效且不易反复复发。
具体原理为:本发明包括中药组合物制得的中药粉,硫磺和氯霉素注射液。中药组合物的部分为:以生杏仁、秦皮、苦楝皮为君药,以木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆为臣药,以水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英为佐药,以甘草为使药;构成的中药组分具有消炎消肿,杀菌解毒,敛疮生肌的效果。
加入的硫磺,属多功能药剂,除有杀菌作用外,还能杀螨和杀虫(螨虫也是造成痤疮的成因之一),功效是外用能杀虫止痒。可用于疥癣、湿疹、皮肤瘙痒。它与皮肤接触后产生硫化氢和五硫磺酸,能杀疥虫,杀霉菌,还能脱毛。硫磺与皮肤及组织接触,在其分泌物的作用下生成硫化物,有使皮肤软化及杀菌作用。
加入的氯霉素:是抑制细菌蛋白质合成的抑菌剂,而痤疮丙酸杆菌(Propionibacterium acnes),也称痤疮杆菌、疮疱丙酸杆菌,是造成青春痘的主要细菌。该细菌能够制造一些分解皮肤组织的酶和免疫原性的蛋白质,氯霉素抑制该细菌分解制造蛋白质。需要注意的是:氯霉素由于其对血液系统的毒性较大,现在已较少使用其来注射或内服,但是,本发明将其外用,忽略其对血液系统的影响。
本发明的酒精,作为溶剂使用,用量多少视实际情况调整即可。
具体实施方式
本发明用于治疗痤疮的中药复配物,其中,包括按照重量单位配置的如下成分:
生杏仁、秦皮、苦楝皮各60-80g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各40-60g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各20-40g,甘草10-20g;硫磺10-30g,2ml:0.25g的氯霉素注射液5-15支,体积分数75%的酒精2000-3000g。
或者,包括按照重量单位配置的如下成分:
生杏仁、秦皮、苦楝皮各60-70g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各40-50g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各20-30g,甘草10-15g;硫磺10-20g,2ml:0.25g的氯霉素注射液5-10支,体积分数75%的酒精2000-2500g。
或者,包括按照重量单位配置的如下成分:
生杏仁、秦皮、苦楝皮各70-80g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各50-60g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各30-40g,甘草15-20g;硫磺20-30g,2ml:0.25g的氯霉素注射液10-15支,体积分数75%的酒精2500-3000g。
或者,包括按照重量单位配置的如下成分:
生杏仁、秦皮、苦楝皮各65-75g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各45-55g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各25-35g,甘草12-18g;硫磺12-22g,2ml:0.25g的氯霉素注射液8-12支,体积分数75%的酒精2200-2600g。
制备方法:
将生杏仁、秦皮、苦楝皮,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英,甘草;
混合一起后加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在80℃,烘干后冷却,得中药粉;
将中药粉,硫磺,2ml:0.25g的氯霉素注射液,倒入体积分数75%的酒精中浸泡48小时后,加热回流提取3次,每次2小时,将3次提取液合并,减压回收乙醇,并浓缩至药液浓度为0.5g生药/ml,即得。
本发明使用时,用棉签或棉棒蘸上述所得药液,涂抹痤疮处,每日三次。
具体举例如下
实施例1:
张先生,24岁,毛孔处形成白头及粉刺。皮层变厚,毛孔附近的组织发炎,引起红肿的暗疮,尤其下巴处较多。局部外用药物维A酸乳膏、阿达帕林凝胶无效,之后口服多西环素效果不佳,痤疮平复后又反复复发。使用本发明:
生杏仁、秦皮、苦楝皮各60g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各40g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各20g,甘草10g;硫磺10g,2ml:0.25g的氯霉素注射液5支,体积分数75%的酒精2000g。
制备方法:将生杏仁、秦皮、苦楝皮,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英,甘草;
混合一起后加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在80℃,烘干后冷却,得中药粉;
将中药粉,硫磺,2ml:0.25g的氯霉素注射液,倒入体积分数75%的酒精中浸泡48小时后,加热回流提取3次,每次2小时,将3次提取液合并,减压回收乙醇,并浓缩至药液浓度为0.5g生药/ml,即得。
本发明使用时,用棉签或棉棒蘸上述所得药液,涂抹痤疮处,每日三次。3天后红肿消退,6天后白头消失,10天后痤疮平复,14天后皮肤恢复平滑。期间保持平淡饮食,3个月后追访,未复发。
实施例2
冯小姐,19岁,粉刺周围的皮肤发红而且稍微突起,具有疼痛感。大量皮脂淤积于毛囊内,堵塞毛囊,溃烂后有粘稠脓液。口服抗生素米诺环素,外用药物维A酸乳膏均无效,使用本发明:
生杏仁、秦皮、苦楝皮各80g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各60g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各40g,甘草20g;硫磺30g,2ml:0.25g的氯霉素注射液15支,体积分数75%的酒精3000g。
制备方法:将生杏仁、秦皮、苦楝皮,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英,甘草;
混合一起后加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在80℃,烘干后冷却,得中药粉;
将中药粉,硫磺,2ml:0.25g的氯霉素注射液,倒入体积分数75%的酒精中浸泡48小时后,加热回流提取3次,每次2小时,将3次提取液合并,减压回收乙醇,并浓缩至药液浓度为0.5g生药/ml,即得。
本发明使用时,用棉签或棉棒蘸上述所得药液,涂抹痤疮处,每日三次。5天后肿痛消退,9天后脓液消失,14天后痤疮平复,18天后皮肤恢复平滑。期间保持平淡饮食,3个月后追访,未复发。
实施例3
严女士,29岁,面部粟粒至豌豆大的小结节,呈半透明红褐色或褐色,触之柔软,中央有坏死,外用药物治疗效果微小,反复复发,使用本发明:
生杏仁、秦皮、苦楝皮各70g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各50g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各30g,甘草15g;硫磺20g,2ml:0.25g的氯霉素注射液10支,体积分数75%的酒精2500g。
制备方法:将生杏仁、秦皮、苦楝皮,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英,甘草;
混合一起后加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在80℃,烘干后冷却,得中药粉;
将中药粉,硫磺,2ml:0.25g的氯霉素注射液,倒入体积分数75%的酒精中浸泡48小时后,加热回流提取3次,每次2小时,将3次提取液合并,减压回收乙醇,并浓缩至药液浓度为0.5g生药/ml,即得。
本发明使用时,用棉签或棉棒蘸上述所得药液,涂抹痤疮处,每日三次。8天后色斑减轻,15天后小结节缩小,一个月后结节消失,皮肤恢复平滑。期间保持平淡饮食,3个月后追访,未复发。
实施例4
金先生,25岁,毛孔出口阻塞,附近的组织发炎,引起红肿的暗疮。顶端有脓头,溃烂后有粘稠脓液。口服抗生素米诺环素后,反复发作,使用本发明:
生杏仁、秦皮、苦楝皮各65g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各45g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各25g,甘草12g;硫磺12g,2ml:0.25g的氯霉素注射液8支,体积分数75%的酒精2200g。
制备方法:将生杏仁、秦皮、苦楝皮,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英,甘草;
混合一起后加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在80℃,烘干后冷却,得中药粉;
将中药粉,硫磺,2ml:0.25g的氯霉素注射液,倒入体积分数75%的酒精中浸泡48小时后,加热回流提取3次,每次2小时,将3次提取液合并,减压回收乙醇,并浓缩至药液浓度为0.5g生药/ml,即得。
本发明使用时,用棉签或棉棒蘸上述所得药液,涂抹痤疮处,每日三次。3天后红肿消退,6天后脓头消失,12天后溃烂消失,18天后皮肤恢复平滑。期间保持平淡饮食,3个月后追访,未复发。
比较实验:
分组:
本发明例子1-4所得药液为组1-组4,
本发明例子1所得中药粉,加水调节为膏状为组5,
硫磺加水调节质量百分比10%为组6,
2ml:0.25g的氯霉素注射液为组7,
背景技术2014103993887所得物为组8,
背景技术2014100851210所得物为组9,
二、抑菌实验:痤疮丙酸杆菌,采用生长速率法,用打孔器取6mm菌落边缘旺盛的菌种,放在加药的PDA平板上培养,以培养基加等量的无菌水做对照,每次重复3次,置于25摄氏度培养,用十字交叉法测每个菌落直径,以平均值代表菌落的直径,以组别1-9分别滴入对应的痤疮丙酸杆菌的培养皿中,在25摄氏度培养箱中培养48小时,观察萌发数量,每处理设5个重复,取平均值,计算萌发率和抑制率。
萌发率%=已萌发数/镜检总数×100%
抑制率%=(对照萌发率-处理萌发率)/对照萌发率×100%
菌落直径(mm)与抑制率(100%),如下表
综上,可以发现:本发明的中药粉(组5)、硫磺(组6)、氯霉素(组7)均对痤疮丙酸杆菌有抑制效果,本发明例子1-4(组1-4)将三者有机结合,得到的抑菌效果明显优于现有技术(组7和组8)。
三治疗效果比较:
筛选270例患者,试验之前1周,对该人群进行连续观察,记录症状及变化,随机分为9组,每组30人。
9组分别使用组1-9的药物,外用治疗一个月后,比较治疗效果:
疗效情况判定标准:治愈:使用本品后,各项指标回复正常;有效:服用和使用本品后,不适症状有所改善;无效:使用本品后,不适症状无变化。
结果如下表所示。
组别 | 病例数 | 有效人数 | 治愈人数 | 无效人数 | 复发人数 | 治愈率 | 总有效率 |
组1 | 30 | 29 | 28 | 1 | 1 | 93.3% | 96.6% |
组2 | 30 | 28 | 26 | 2 | 2 | 86.6% | 93.3% |
组3 | 30 | 28 | 26 | 2 | 2 | 86.6% | 93.3% |
组4 | 30 | 27 | 25 | 3 | 2 | 83.3% | 90% |
组5 | 30 | 26 | 23 | 3 | 4 | 76.6% | 86.6% |
组6 | 30 | 27 | 23 | 4 | 3 | 76.6% | 90% |
组7 | 30 | 27 | 24 | 3 | 3 | 80% | 90% |
组8 | 30 | 26 | 22 | 4 | 4 | 73.3% | 86.6% |
组9 | 30 | 27 | 22 | 5 | 3 | 73.3% | 90% |
通过上表可以发现,本发明的组1-4的治疗效果明显优于现有技术(组7和组8),也较单纯的中药粉(组5)、硫磺(组6)、氯霉素(组7)的治疗效果好。
综上,本发明配比简单,使用方便,杀菌效果好,抑制皮脂分泌,治疗痤疮快速见效且不易反复复发。
具体原理为:本发明包括中药组合物制得的中药粉,硫磺和氯霉素注射液。中药组合物的部分为:以生杏仁、秦皮、苦楝皮为君药,以木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆为臣药,以水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英为佐药,以甘草为使药;构成的中药组分具有消炎消肿,杀菌解毒,敛疮生肌的效果。
加入的硫磺,属多功能药剂,除有杀菌作用外,还能杀螨和杀虫(螨虫也是造成痤疮的成因之一),功效是外用能杀虫止痒。可用于疥癣、湿疹、皮肤瘙痒。它与皮肤接触后产生硫化氢和五硫磺酸,能杀疥虫,杀霉菌,还能脱毛。硫磺与皮肤及组织接触,在其分泌物的作用下生成硫化物,有使皮肤软化及杀菌作用。
加入的氯霉素:是抑制细菌蛋白质合成的抑菌剂,而痤疮丙酸杆菌(Propionibacterium acnes),也称痤疮杆菌、疮疱丙酸杆菌,是造成青春痘的主要细菌。该细菌能够制造一些分解皮肤组织的酶和免疫原性的蛋白质,氯霉素抑制该细菌分解制造蛋白质。需要注意的是:氯霉素由于其对血液系统的毒性较大,现在已较少使用其来注射或内服,但是,本发明将其外用,忽略其对血液系统的影响。
Claims (5)
1.一种用于治疗痤疮的中药复配物,其特征在于,包括按照重量单位配置的如下成分:
生杏仁、秦皮、苦楝皮各60-80g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各40-60g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各20-40g,甘草10-20g;硫磺10-30g,2ml∶0.25g的氯霉素注射液5-15支,体积分数75%的酒精2000-3000g。
2.根据权利要求1所述用于治疗痤疮的中药复配物,其特征在于,包括按照重量单位配置的如下成分:
生杏仁、秦皮、苦楝皮各60-70g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各40-50g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各20-30g,甘草10-15g;硫磺10-20g,2ml∶0.25g的氯霉素注射液5-10支,体积分数75%的酒精2000-2500g。
3.根据权利要求1所述用于治疗痤疮的中药复配物,其特征在于,包括按照重量单位配置的如下成分:
生杏仁、秦皮、苦楝皮各70-80g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各50-60g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各30-40g,甘草15-20g;硫磺20-30g,2ml∶0.25g的氯霉素注射液10-15支,体积分数75%的酒精2500-3000g。
4.根据权利要求1所述用于治疗痤疮的中药复配物,其特征在于,包括按照重量单位配置的如下成分:
生杏仁、秦皮、苦楝皮各65-75g,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆各45-55g,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英各25-35g,甘草12-18g;硫磺12-22g,2ml∶0.25g的氯霉素注射液8-12支,体积分数75%的酒精2200-2600g。
5.一种如权利要求1-4任一所述用于治疗痤疮的中药复配物的制备方法,其特征在于,
将生杏仁、秦皮、苦楝皮,木芙蓉叶、野菊花、黄芩、大青叶、血竭、巴豆,水牛角、丝瓜络、金钱草、艾叶、冰片、黄药子、地榆、蒲公英,甘草;
混合一起后加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在80℃,烘干后冷却,得中药粉;
将中药粉,硫磺,2ml∶0.25g的氯霉素注射液,倒入体积分数75%的酒精中浸泡48小时后,加热回流提取3次,每次2小时,将3次提取液合并,减压回收乙醇,并浓缩至药液浓度为0.5g生药/ml,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610188990.5A CN105878665A (zh) | 2016-03-21 | 2016-03-21 | 一种用于治疗痤疮的中药复配物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610188990.5A CN105878665A (zh) | 2016-03-21 | 2016-03-21 | 一种用于治疗痤疮的中药复配物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105878665A true CN105878665A (zh) | 2016-08-24 |
Family
ID=57013970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610188990.5A Pending CN105878665A (zh) | 2016-03-21 | 2016-03-21 | 一种用于治疗痤疮的中药复配物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105878665A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108143803A (zh) * | 2018-03-05 | 2018-06-12 | 广州市尚昇生物科技有限公司 | 一种祛痘液及其生产工艺和应用 |
CN110420245A (zh) * | 2019-07-24 | 2019-11-08 | 杜晓欢 | 一种用于治疗痤疮的中药外敷药及其制备方法 |
-
2016
- 2016-03-21 CN CN201610188990.5A patent/CN105878665A/zh active Pending
Non-Patent Citations (1)
Title |
---|
南京中医药大学编著: "《中药大辞典》", 31 March 2006, 上海科学技术出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108143803A (zh) * | 2018-03-05 | 2018-06-12 | 广州市尚昇生物科技有限公司 | 一种祛痘液及其生产工艺和应用 |
CN110420245A (zh) * | 2019-07-24 | 2019-11-08 | 杜晓欢 | 一种用于治疗痤疮的中药外敷药及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102697961B (zh) | 一种治疗阴道炎的妇科清洗液及其制作方法 | |
CN102389515B (zh) | 一种防治痤疮皮肤病的外用中药擦剂及其制备方法 | |
CN101537107A (zh) | 有效治疗皮肤真菌病的外用擦剂及其制备方法 | |
CN101019948A (zh) | 治疗痤疮的中药复方制剂 | |
CN105232725A (zh) | 一种祛痘配方及其制备方法 | |
CN102266471A (zh) | 一种消痈化疡的中药软膏 | |
CN105727236A (zh) | 治疗招财鱼赤皮病的散剂及其制备方法 | |
CN102068527B (zh) | 一种根除青春痘的药物 | |
CN101439114B (zh) | 一种治疗烧烫伤的中药及其制备方法 | |
CN105878665A (zh) | 一种用于治疗痤疮的中药复配物及其制备方法 | |
CN101972391A (zh) | 用于治疗猪乳房炎的药物组合物及其制备方法 | |
CN103495085B (zh) | 一种治疗放射性皮炎的中药制剂 | |
CN104491569A (zh) | 一种治疗青春痘的中药配方 | |
CN105012818A (zh) | 一种治疗妇科炎症的组合物及其制剂和制法 | |
CN105727028A (zh) | 治疗痤疮的中药组合物 | |
CN103393951B (zh) | 冻疮酊 | |
CN106619286A (zh) | 一种痤疮防治美容中药面膜 | |
CN105641265A (zh) | 一种用于治疗痤疮的芦荟组合药物、其制剂及其应用 | |
CN105816670A (zh) | 抑制疮疱丙酸杆菌的粉刺治疗药 | |
CN104323960A (zh) | 一种祛痘美白的中药面膜及制备方法 | |
CN102895471B (zh) | 一种治疗痤疮、毛囊炎、脓疱疹的药物及其制备方法 | |
CN103720927A (zh) | 一种用于治疗奶牛乳房炎症的中药制剂 | |
CN108542934A (zh) | 一种防治粉刺皮肤病的外用中药擦剂及其制备方法 | |
CN101991664B (zh) | 一种治疗痤疮的凝胶剂及其制备方法 | |
CN105726681A (zh) | 一种治疗奶牛子宫内膜炎的注射液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160824 |
|
RJ01 | Rejection of invention patent application after publication |